Aclaris Therapeutics, Inc. (LON:0H8T)
1.270
+0.031 (2.49%)
At close: May 16, 2025
Aclaris Therapeutics Employees
As of December 31, 2024, Aclaris Therapeutics had 64 total employees, including 61 full-time and 3 part-time employees. The number of employees decreased by 27 or -29.67% compared to the previous year.
Employees
64
Change (1Y)
-27
Growth (1Y)
-29.67%
Revenue / Employee
218.40K GBP
Profits / Employee
-1.60M GBP
Market Cap
109.35M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Aclaris Therapeutics News
- 11 days ago - Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series - GlobeNewsWire
- 12 days ago - Aclaris Therapeutics GAAP EPS of -$0.12, revenue of $1.46M - Seeking Alpha
- 12 days ago - Aclaris Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 21 days ago - Aclaris Therapeutics Appoints Jesse Hall, M.D. as Chief Medical Officer - GlobeNewsWire
- 4 weeks ago - Aclaris Therapeutics gets FDA nod to begin trial of ATI-052 - Seeking Alpha
- 2 months ago - Aclaris Therapeutics to Participate in Two March Healthcare Conferences - GlobeNewsWire
- 2 months ago - Aclaris Therapeutics plans $300M mixed shelf offering - Seeking Alpha
- 3 months ago - New Publication Highlights Unique Properties of ATI-2138, a Potent and Selective Inhibitor of ITK and JAK3 - GlobeNewsWire